Analytical Data
-
Gene name
ANKRD22
- Application
-
Alternative Names
ANKRD22Ankyrin repeat domain-containing Protein 22
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5VYY1
-
Expression Region
1-191aa
-
AA Sequence
MGILYSEPICQAAYQNDFGQVWRWVKEDSSYANVQDGFNGDTPLICACRRGHVRIVSFLLRRNANVNLKNQKERTCLHHAVKKKFTFIDYLLIILLMPVLLIGYFLMVSKTKQNEALVRMLLDAGVEVNATDCYGCTALHYACEMKNQSLIPLLLEARADPTIKNKHGESSLDIARRLKFSQIELMLRKAL
-
Molecular Weight
48.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ANKRD22, also known as Ankyrin Repeat Domain 22, is a protein that has garnered research attention due to its potential roles in cellular signaling and various diseases. It is part of the ankyrin repeat-containing protein family, which is known for its involvement in protein-protein interactions, influencing cellular processes like proliferation, differentiation, and apoptosis. The interest in ANKRD22 stems from its possible implications in cancer biology, where aberrations in its expression or function could contribute to tumorigenesis and metastasis. Additionally, ANKRD22 has been associated with neurodegenerative disorders, suggesting its role in maintaining neuronal health. Recent studies have indicated that ANKRD22 might be involved in regulating immune responses, further broadening its research scope. Investigating the properties and functions of ANKRD22 could reveal critical insights into its mechanisms of action, potentially leading to novel therapeutic targets for various diseases. Therefore, the development of recombinant ANKRD22 is vital for elucidating its biological functions, establishing its role in disease mechanisms, and exploring its therapeutic potential.
